AN2 THERAPEUTICS INC (ANTX) Stock Earnings & Estimates
NASDAQ:ANTX - US0373261058 - Common Stock
1.14 USD
-0.01 (-0.87%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.18M | -7.28M -40.54% | -21.57M -196.29% | -42.26M -95.92% | -69.635M -64.78% | -54.554M 21.66% | N/A 29.33% | N/A 19.84% | N/A -15.84% | N/A -25.64% | N/A 8.16% | N/A -7.65% | N/A -7.57% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -4.71 | -2.82 40.13% | -1.64 41.84% | N/A 37.18% | N/A 4.95% | N/A 12.50% | N/A -50.00% | N/A -7.94% | N/A -7.35% | N/A -7.53% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.22 35.89% | -0.22 10.24% | -0.24 30.06% | -0.24 -16.57% | -0.24 -9.09% | -0.24 -9.09% |
| Revenue Q2Q % growth | ||||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.446M 36.74% | -7.548M 12.30% | -7.548M 34.58% | -7.65M -6.01% | -7.752M -4.11% | -7.854M -4.05% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.21 56.25% | -0.34 | 0.13 | 38.17% |
| Q1 2025 Q2Q % growth | -0.35 37.50% | -0.26 | -0.09 | -32.10% |
| Q4 2024 Q2Q % growth | -0.25 56.14% | -0.26 | 0.01 | 3.88% |
| Q3 2024 Q2Q % growth | -0.35 46.15% | -0.39 | 0.04 | 10.87% |
| Q2 2024 Q2Q % growth | -0.48 40.74% | -0.61 | 0.13 | 20.68% |
| Q1 2024 Q2Q % growth | -0.56 29.11% | -0.63 | 0.07 | 11.56% |
| Q4 2023 Q2Q % growth | -0.57 6.56% | -0.76 | 0.19 | 25.07% |
| Q3 2023 Q2Q % growth | -0.65 -10.17% | -0.64 | -0.01 | -1.69% |
| Q2 2023 Q2Q % growth | -0.81 -52.83% | -0.87 | 0.06 | 6.94% |
| Q1 2023 Q2Q % growth | -0.79 73.49% | -0.69 | -0.10 | -13.90% |
| Q4 2022 Q2Q % growth | -0.61 | -0.66 | 0.05 | 7.52% |
| Q3 2022 Q2Q % growth | -0.59 | -0.61 | 0.02 | 2.51% |
| Q2 2022 Q2Q % growth | -0.53 | -0.46 | -0.07 | -14.03% |
| Q1 2022 Q2Q % growth | -2.98 | -0.53 | -2.45 | -458.27% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 30.38% | 18.52% | 18.57% | 13.88% |
| Revenue | N/A | N/A | N/A | N/A |